Table of Content

1 Study Coverage
1.1 Vaccine for Influenza Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine for Influenza Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Vaccine for Influenza Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vaccine for Influenza Sales Estimates and Forecasts 2018-2029
2.2 Global Vaccine for Influenza Revenue by Region
2.2.1 Global Vaccine for Influenza Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Vaccine for Influenza Revenue by Region (2018-2024)
2.2.3 Global Vaccine for Influenza Revenue by Region (2024-2029)
2.2.4 Global Vaccine for Influenza Revenue Market Share by Region (2018-2029)
2.3 Global Vaccine for Influenza Sales Estimates and Forecasts 2018-2029
2.4 Global Vaccine for Influenza Sales by Region
2.4.1 Global Vaccine for Influenza Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Vaccine for Influenza Sales by Region (2018-2024)
2.4.3 Global Vaccine for Influenza Sales by Region (2024-2029)
2.4.4 Global Vaccine for Influenza Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Vaccine for Influenza Sales by Manufacturers
3.1.1 Global Vaccine for Influenza Sales by Manufacturers (2018-2024)
3.1.2 Global Vaccine for Influenza Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine for Influenza in 2022
3.2 Global Vaccine for Influenza Revenue by Manufacturers
3.2.1 Global Vaccine for Influenza Revenue by Manufacturers (2018-2024)
3.2.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Vaccine for Influenza Revenue in 2022
3.3 Global Key Players of Vaccine for Influenza, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Vaccine for Influenza Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vaccine for Influenza, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vaccine for Influenza, Product Offered and Application
3.8 Global Key Manufacturers of Vaccine for Influenza, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccine for Influenza Sales by Type
4.1.1 Global Vaccine for Influenza Historical Sales by Type (2018-2024)
4.1.2 Global Vaccine for Influenza Forecasted Sales by Type (2024-2029)
4.1.3 Global Vaccine for Influenza Sales Market Share by Type (2018-2029)
4.2 Global Vaccine for Influenza Revenue by Type
4.2.1 Global Vaccine for Influenza Historical Revenue by Type (2018-2024)
4.2.2 Global Vaccine for Influenza Forecasted Revenue by Type (2024-2029)
4.2.3 Global Vaccine for Influenza Revenue Market Share by Type (2018-2029)
4.3 Global Vaccine for Influenza Price by Type
4.3.1 Global Vaccine for Influenza Price by Type (2018-2024)
4.3.2 Global Vaccine for Influenza Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Vaccine for Influenza Sales by Application
5.1.1 Global Vaccine for Influenza Historical Sales by Application (2018-2024)
5.1.2 Global Vaccine for Influenza Forecasted Sales by Application (2024-2029)
5.1.3 Global Vaccine for Influenza Sales Market Share by Application (2018-2029)
5.2 Global Vaccine for Influenza Revenue by Application
5.2.1 Global Vaccine for Influenza Historical Revenue by Application (2018-2024)
5.2.2 Global Vaccine for Influenza Forecasted Revenue by Application (2024-2029)
5.2.3 Global Vaccine for Influenza Revenue Market Share by Application (2018-2029)
5.3 Global Vaccine for Influenza Price by Application
5.3.1 Global Vaccine for Influenza Price by Application (2018-2024)
5.3.2 Global Vaccine for Influenza Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Vaccine for Influenza Market Size by Type
6.1.1 US & Canada Vaccine for Influenza Sales by Type (2018-2029)
6.1.2 US & Canada Vaccine for Influenza Revenue by Type (2018-2029)
6.2 US & Canada Vaccine for Influenza Market Size by Application
6.2.1 US & Canada Vaccine for Influenza Sales by Application (2018-2029)
6.2.2 US & Canada Vaccine for Influenza Revenue by Application (2018-2029)
6.3 US & Canada Vaccine for Influenza Market Size by Country
6.3.1 US & Canada Vaccine for Influenza Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Vaccine for Influenza Sales by Country (2018-2029)
6.3.3 US & Canada Vaccine for Influenza Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Vaccine for Influenza Market Size by Type
7.1.1 Europe Vaccine for Influenza Sales by Type (2018-2029)
7.1.2 Europe Vaccine for Influenza Revenue by Type (2018-2029)
7.2 Europe Vaccine for Influenza Market Size by Application
7.2.1 Europe Vaccine for Influenza Sales by Application (2018-2029)
7.2.2 Europe Vaccine for Influenza Revenue by Application (2018-2029)
7.3 Europe Vaccine for Influenza Market Size by Country
7.3.1 Europe Vaccine for Influenza Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Vaccine for Influenza Sales by Country (2018-2029)
7.3.3 Europe Vaccine for Influenza Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Vaccine for Influenza Market Size
8.1.1 China Vaccine for Influenza Sales (2018-2029)
8.1.2 China Vaccine for Influenza Revenue (2018-2029)
8.2 China Vaccine for Influenza Market Size by Application
8.2.1 China Vaccine for Influenza Sales by Application (2018-2029)
8.2.2 China Vaccine for Influenza Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Vaccine for Influenza Market Size by Type
9.1.1 Asia Vaccine for Influenza Sales by Type (2018-2029)
9.1.2 Asia Vaccine for Influenza Revenue by Type (2018-2029)
9.2 Asia Vaccine for Influenza Market Size by Application
9.2.1 Asia Vaccine for Influenza Sales by Application (2018-2029)
9.2.2 Asia Vaccine for Influenza Revenue by Application (2018-2029)
9.3 Asia Vaccine for Influenza Sales by Region
9.3.1 Asia Vaccine for Influenza Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Vaccine for Influenza Revenue by Region (2018-2029)
9.3.3 Asia Vaccine for Influenza Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vaccine for Influenza Market Size by Type
10.1.1 Middle East, Africa and Latin America Vaccine for Influenza Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Vaccine for Influenza Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Vaccine for Influenza Market Size by Application
10.2.1 Middle East, Africa and Latin America Vaccine for Influenza Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Vaccine for Influenza Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Vaccine for Influenza Sales by Country
10.3.1 Middle East, Africa and Latin America Vaccine for Influenza Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Vaccine for Influenza Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Vaccine for Influenza Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSL Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Overview
11.3.3 GSK Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GSK Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Viatris
11.4.1 Viatris Company Information
11.4.2 Viatris Overview
11.4.3 Viatris Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Viatris Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Viatris Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 AstraZeneca Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Company Information
11.6.2 Hualan Bio Overview
11.6.3 Hualan Bio Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Hualan Bio Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hualan Bio Recent Developments
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Company Information
11.7.2 Changchun Institute of Biological Overview
11.7.3 Changchun Institute of Biological Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Changchun Institute of Biological Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Changchun Institute of Biological Recent Developments
11.8 Sinovac
11.8.1 Sinovac Company Information
11.8.2 Sinovac Overview
11.8.3 Sinovac Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Sinovac Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sinovac Recent Developments
11.9 BCHT
11.9.1 BCHT Company Information
11.9.2 BCHT Overview
11.9.3 BCHT Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 BCHT Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BCHT Recent Developments
11.10 Jiangsu GDK
11.10.1 Jiangsu GDK Company Information
11.10.2 Jiangsu GDK Overview
11.10.3 Jiangsu GDK Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Jiangsu GDK Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jiangsu GDK Recent Developments
11.11 KM Biologics
11.11.1 KM Biologics Company Information
11.11.2 KM Biologics Overview
11.11.3 KM Biologics Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 KM Biologics Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 KM Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaccine for Influenza Industry Chain Analysis
12.2 Vaccine for Influenza Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccine for Influenza Production Mode & Process
12.4 Vaccine for Influenza Sales and Marketing
12.4.1 Vaccine for Influenza Sales Channels
12.4.2 Vaccine for Influenza Distributors
12.5 Vaccine for Influenza Customers
13 Market Dynamics
13.1 Vaccine for Influenza Industry Trends
13.2 Vaccine for Influenza Market Drivers
13.3 Vaccine for Influenza Market Challenges
13.4 Vaccine for Influenza Market Restraints
14 Key Findings in The Global Vaccine for Influenza Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Vaccine for Influenza Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Trivalent Influenza Vaccine
Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 4. Global Vaccine for Influenza Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Vaccine for Influenza Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Vaccine for Influenza Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Vaccine for Influenza Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Vaccine for Influenza Revenue Market Share by Region (2018-2024)
Table 9. Global Vaccine for Influenza Revenue Market Share by Region (2024-2029)
Table 10. Global Vaccine for Influenza Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Vaccine for Influenza Sales by Region (2018-2024) & (M Units)
Table 12. Global Vaccine for Influenza Sales by Region (2024-2029) & (M Units)
Table 13. Global Vaccine for Influenza Sales Market Share by Region (2018-2024)
Table 14. Global Vaccine for Influenza Sales Market Share by Region (2024-2029)
Table 15. Global Vaccine for Influenza Sales by Manufacturers (2018-2024) & (M Units)
Table 16. Global Vaccine for Influenza Sales Share by Manufacturers (2018-2024)
Table 17. Global Vaccine for Influenza Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Vaccine for Influenza Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Vaccine for Influenza, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Vaccine for Influenza Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Vaccine for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Vaccine for Influenza by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2022)
Table 23. Global Key Manufacturers of Vaccine for Influenza, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Vaccine for Influenza, Product Offered and Application
Table 25. Global Key Manufacturers of Vaccine for Influenza, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vaccine for Influenza Sales by Type (2018-2024) & (M Units)
Table 28. Global Vaccine for Influenza Sales by Type (2024-2029) & (M Units)
Table 29. Global Vaccine for Influenza Sales Share by Type (2018-2024)
Table 30. Global Vaccine for Influenza Sales Share by Type (2024-2029)
Table 31. Global Vaccine for Influenza Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Vaccine for Influenza Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Vaccine for Influenza Revenue Share by Type (2018-2024)
Table 34. Global Vaccine for Influenza Revenue Share by Type (2024-2029)
Table 35. Vaccine for Influenza Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Vaccine for Influenza Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Vaccine for Influenza Sales by Application (2018-2024) & (M Units)
Table 38. Global Vaccine for Influenza Sales by Application (2024-2029) & (M Units)
Table 39. Global Vaccine for Influenza Sales Share by Application (2018-2024)
Table 40. Global Vaccine for Influenza Sales Share by Application (2024-2029)
Table 41. Global Vaccine for Influenza Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Vaccine for Influenza Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Vaccine for Influenza Revenue Share by Application (2018-2024)
Table 44. Global Vaccine for Influenza Revenue Share by Application (2024-2029)
Table 45. Vaccine for Influenza Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Vaccine for Influenza Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Vaccine for Influenza Sales by Type (2018-2024) & (M Units)
Table 48. US & Canada Vaccine for Influenza Sales by Type (2024-2029) & (M Units)
Table 49. US & Canada Vaccine for Influenza Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Vaccine for Influenza Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Vaccine for Influenza Sales by Application (2018-2024) & (M Units)
Table 52. US & Canada Vaccine for Influenza Sales by Application (2024-2029) & (M Units)
Table 53. US & Canada Vaccine for Influenza Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Vaccine for Influenza Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Vaccine for Influenza Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Vaccine for Influenza Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Vaccine for Influenza Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 59. US & Canada Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 60. Europe Vaccine for Influenza Sales by Type (2018-2024) & (M Units)
Table 61. Europe Vaccine for Influenza Sales by Type (2024-2029) & (M Units)
Table 62. Europe Vaccine for Influenza Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Vaccine for Influenza Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Vaccine for Influenza Sales by Application (2018-2024) & (M Units)
Table 65. Europe Vaccine for Influenza Sales by Application (2024-2029) & (M Units)
Table 66. Europe Vaccine for Influenza Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Vaccine for Influenza Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Vaccine for Influenza Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Vaccine for Influenza Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Vaccine for Influenza Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 72. Europe Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 73. China Vaccine for Influenza Sales by Type (2018-2024) & (M Units)
Table 74. China Vaccine for Influenza Sales by Type (2024-2029) & (M Units)
Table 75. China Vaccine for Influenza Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Vaccine for Influenza Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Vaccine for Influenza Sales by Application (2018-2024) & (M Units)
Table 78. China Vaccine for Influenza Sales by Application (2024-2029) & (M Units)
Table 79. China Vaccine for Influenza Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Vaccine for Influenza Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Vaccine for Influenza Sales by Type (2018-2024) & (M Units)
Table 82. Asia Vaccine for Influenza Sales by Type (2024-2029) & (M Units)
Table 83. Asia Vaccine for Influenza Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Vaccine for Influenza Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Vaccine for Influenza Sales by Application (2018-2024) & (M Units)
Table 86. Asia Vaccine for Influenza Sales by Application (2024-2029) & (M Units)
Table 87. Asia Vaccine for Influenza Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Vaccine for Influenza Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Vaccine for Influenza Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Vaccine for Influenza Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Vaccine for Influenza Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Vaccine for Influenza Sales by Region (2018-2024) & (M Units)
Table 93. Asia Vaccine for Influenza Sales by Region (2024-2029) & (M Units)
Table 94. Middle East, Africa and Latin America Vaccine for Influenza Sales by Type (2018-2024) & (M Units)
Table 95. Middle East, Africa and Latin America Vaccine for Influenza Sales by Type (2024-2029) & (M Units)
Table 96. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Vaccine for Influenza Sales by Application (2018-2024) & (M Units)
Table 99. Middle East, Africa and Latin America Vaccine for Influenza Sales by Application (2024-2029) & (M Units)
Table 100. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Vaccine for Influenza Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 106. Middle East, Africa and Latin America Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. CSL Company Information
Table 113. CSL Description and Major Businesses
Table 114. CSL Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. CSL Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSL Recent Developments
Table 117. GSK Company Information
Table 118. GSK Description and Major Businesses
Table 119. GSK Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. GSK Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. GSK Recent Developments
Table 122. Viatris Company Information
Table 123. Viatris Description and Major Businesses
Table 124. Viatris Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Viatris Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Viatris Recent Developments
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Description and Major Businesses
Table 129. AstraZeneca Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. AstraZeneca Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. AstraZeneca Recent Developments
Table 132. Hualan Bio Company Information
Table 133. Hualan Bio Description and Major Businesses
Table 134. Hualan Bio Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Hualan Bio Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hualan Bio Recent Developments
Table 137. Changchun Institute of Biological Company Information
Table 138. Changchun Institute of Biological Description and Major Businesses
Table 139. Changchun Institute of Biological Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Changchun Institute of Biological Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Changchun Institute of Biological Recent Developments
Table 142. Sinovac Company Information
Table 143. Sinovac Description and Major Businesses
Table 144. Sinovac Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Sinovac Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sinovac Recent Developments
Table 147. BCHT Company Information
Table 148. BCHT Description and Major Businesses
Table 149. BCHT Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. BCHT Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. BCHT Recent Developments
Table 152. Jiangsu GDK Company Information
Table 153. Jiangsu GDK Description and Major Businesses
Table 154. Jiangsu GDK Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Jiangsu GDK Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Jiangsu GDK Recent Developments
Table 157. KM Biologics Company Information
Table 158. KM Biologics Description and Major Businesses
Table 159. KM Biologics Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. KM Biologics Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. KM Biologics Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Vaccine for Influenza Distributors List
Table 165. Vaccine for Influenza Customers List
Table 166. Vaccine for Influenza Market Trends
Table 167. Vaccine for Influenza Market Drivers
Table 168. Vaccine for Influenza Market Challenges
Table 169. Vaccine for Influenza Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine for Influenza Product Picture
Figure 2. Global Vaccine for Influenza Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vaccine for Influenza Market Share by Type in 2022 & 2029
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Vaccine for Influenza Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Vaccine for Influenza Market Share by Application in 2022 & 2029
Figure 8. 6 Months to 3 Years
Figure 9. > 3 Years
Figure 10. Vaccine for Influenza Report Years Considered
Figure 11. Global Vaccine for Influenza Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Vaccine for Influenza Revenue 2018-2029 (US$ Million)
Figure 13. Global Vaccine for Influenza Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Vaccine for Influenza Revenue Market Share by Region (2018-2029)
Figure 15. Global Vaccine for Influenza Sales 2018-2029 ((M Units)
Figure 16. Global Vaccine for Influenza Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Vaccine for Influenza Sales YoY (2018-2029) & (M Units)
Figure 18. US & Canada Vaccine for Influenza Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Vaccine for Influenza Sales YoY (2018-2029) & (M Units)
Figure 20. Europe Vaccine for Influenza Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Vaccine for Influenza Sales YoY (2018-2029) & (M Units)
Figure 22. China Vaccine for Influenza Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Vaccine for Influenza Sales YoY (2018-2029) & (M Units)
Figure 24. Asia (excluding China) Vaccine for Influenza Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Vaccine for Influenza Sales YoY (2018-2029) & (M Units)
Figure 26. Middle East, Africa and Latin America Vaccine for Influenza Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Vaccine for Influenza Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Vaccine for Influenza in the World: Market Share by Vaccine for Influenza Revenue in 2022
Figure 29. Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Vaccine for Influenza Sales Market Share by Type (2018-2029)
Figure 31. Global Vaccine for Influenza Revenue Market Share by Type (2018-2029)
Figure 32. Global Vaccine for Influenza Sales Market Share by Application (2018-2029)
Figure 33. Global Vaccine for Influenza Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Vaccine for Influenza Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Vaccine for Influenza Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Vaccine for Influenza Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Vaccine for Influenza Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Vaccine for Influenza Revenue Share by Country (2018-2029)
Figure 39. US & Canada Vaccine for Influenza Sales Share by Country (2018-2029)
Figure 40. U.S. Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Vaccine for Influenza Sales Market Share by Type (2018-2029)
Figure 43. Europe Vaccine for Influenza Revenue Market Share by Type (2018-2029)
Figure 44. Europe Vaccine for Influenza Sales Market Share by Application (2018-2029)
Figure 45. Europe Vaccine for Influenza Revenue Market Share by Application (2018-2029)
Figure 46. Europe Vaccine for Influenza Revenue Share by Country (2018-2029)
Figure 47. Europe Vaccine for Influenza Sales Share by Country (2018-2029)
Figure 48. Germany Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 49. France Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 53. China Vaccine for Influenza Sales Market Share by Type (2018-2029)
Figure 54. China Vaccine for Influenza Revenue Market Share by Type (2018-2029)
Figure 55. China Vaccine for Influenza Sales Market Share by Application (2018-2029)
Figure 56. China Vaccine for Influenza Revenue Market Share by Application (2018-2029)
Figure 57. Asia Vaccine for Influenza Sales Market Share by Type (2018-2029)
Figure 58. Asia Vaccine for Influenza Revenue Market Share by Type (2018-2029)
Figure 59. Asia Vaccine for Influenza Sales Market Share by Application (2018-2029)
Figure 60. Asia Vaccine for Influenza Revenue Market Share by Application (2018-2029)
Figure 61. Asia Vaccine for Influenza Revenue Share by Region (2018-2029)
Figure 62. Asia Vaccine for Influenza Sales Share by Region (2018-2029)
Figure 63. Japan Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 67. India Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Vaccine for Influenza Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Vaccine for Influenza Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Vaccine for Influenza Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Vaccine for Influenza Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Vaccine for Influenza Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Vaccine for Influenza Sales Share by Country (2018-2029)
Figure 74. Brazil Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Vaccine for Influenza Revenue (2018-2029) & (US$ Million)
Figure 79. Vaccine for Influenza Value Chain
Figure 80. Vaccine for Influenza Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed